The FDA announced on 2014-10-16 that Apotex Inc. is recalling Candesartan Cilexetil Tablets, 4 mg, due to failed impurity specifications. The agency stated the recall was voluntary and initiated by the firm.
How to tell if you have it
- Brand: Apotex
- Product: Candesartan Cilexetil Tablets 4 mg
- Packaging: 30-count bottle, Rx Only
- NDC: 60505-3618-3
- Lot codes: KR3924, KR3926
- Expiration date: 11/15
- Manufacturer: Apotex Research Pvt. Ltd., Bangalore-560 099, India
- Distributor: Nationwide
- Units affected: 13,177 bottles
The hazard
The recall addresses out-of-specification results for CAD-II, CAD-V, and Total Impurities in the tablets. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Apotex Inc. has 19 other recalls on record since 2020-05-27. Other recent recalls of similar products include Apotex Metformin Tablets Recall (2020-05-27), Apotex Atorvastatin 40mg Tablets Recall (2019-10-22), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall (2019-09-24). Additional recent recalls include Apotex Paxil CR 37.5mg Tablets Recall (2026-08-13), Apotex Recalls Paroxetine 37.5mg Due to Dissolution Failure (2026-09-23), and Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (2026-09-18).